EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 370 filers reported holding EXELIXIS INC in Q3 2020. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,834 | +4.8% | 9,878 | 0.0% | 0.02% | -11.5% |
| Q2 2022 | $206,000 | -8.0% | 9,878 | 0.0% | 0.03% | 0.0% |
| Q1 2022 | $224,000 | +7.2% | 9,878 | 0.0% | 0.03% | +8.3% |
| Q3 2021 | $209,000 | -6.3% | 9,878 | 0.0% | 0.02% | -11.1% |
| Q1 2021 | $223,000 | -7.9% | 9,878 | 0.0% | 0.03% | -25.0% |
| Q3 2020 | $242,000 | +3.0% | 9,878 | 0.0% | 0.04% | -2.7% |
| Q2 2020 | $235,000 | +11.4% | 9,878 | 0.0% | 0.04% | +8.8% |
| Q2 2019 | $211,000 | -10.2% | 9,878 | 0.0% | 0.03% | -8.1% |
| Q1 2019 | $235,000 | +21.1% | 9,878 | 0.0% | 0.04% | +48.0% |
| Q4 2018 | $194,000 | +10.9% | 9,878 | 0.0% | 0.02% | -3.8% |
| Q3 2018 | $175,000 | -17.8% | 9,878 | 0.0% | 0.03% | -13.3% |
| Q2 2018 | $213,000 | – | 9,878 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |